Fish-oil dietary supplementation in patients with Raynaud's phenomenon: a double-blind, controlled, prospective study.
暂无分享,去创建一个
[1] S. A. Sanchez. Strain Gauge Plethysmography: A Diagnostic Aid in Obstructive Arterial Disease , 1966 .
[2] J. Ludbrook,et al. Cold Hypersensitivity in Raynaud's Phenomenon , 1971 .
[3] J. Ferrendelli,et al. Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[4] B. Scherer,et al. PLATELET-MEMBRANE FATTY ACIDS, PLATELET AGGREGATION, AND THROMBOXANE FORMATION DURING A MACKEREL DIET , 1980, The Lancet.
[5] A. Masi. Preliminary criteria for the classification of systemic sclerosis (scleroderma). , 1980, Bulletin on the rheumatic diseases.
[6] P. Weber,et al. Platelet Function, Thromboxane Formation and Blood Pressure Control During Supplementation of the Western Diet with Cod Liver Oil , 1983, Circulation.
[7] T. Hamazaki,et al. Effect of oral administration of highly purified eicosapentaenoic acid on platelet function, blood viscosity and red cell deformability in healthy human subjects. , 1983, Atherosclerosis.
[8] P. Weber,et al. Thromboxane A3 (TXA3) is formed in human platelets after dietary eicosapentaenoic acid (C20:5ω3) , 1983 .
[9] R. Rodeheffer,et al. Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon. , 1983, The New England journal of medicine.
[10] J. Seibold,et al. Treatment of Raynaud's phenomenon with ketanserin, a selective antagonist of the serotonin2 (5-HT2) receptor. , 1984, Arthritis and rheumatism.
[11] P. Weber,et al. Prostaglandin I3 is formed in vivo in man after dietary eicosapentaenoic acid , 1984, Nature.
[12] R. Cotran,et al. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells , 1984, The Journal of experimental medicine.
[13] E. Eichner. Platelets, carotids, and coronaries. Critique on antithrombotic role of antiplatelet agents, exercise, and certain diets. , 1984, The American journal of medicine.
[14] C von Schacky,et al. Long-term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans. , 1985 .
[15] V. Pollak,et al. Enhancing effect of dietary supplementation with omega-3 fatty acids on plasma fibrinolysis in normal subjects. , 1985, Thrombosis research.
[16] F E Preston,et al. The effects of dietary omega-3 polyunsaturated fatty acids on erythrocyte membrane phospholipids, erythrocyte deformability and blood viscosity in healthy volunteers. , 1985, Atherosclerosis.
[17] R. Rynes,et al. EFFECTS OF MANIPULATION OF DIETARY FATTY ACIDS ON CLINICAL MANIFESTATIONS OF RHEUMATOID ARTHRITIS , 1985, The Lancet.
[18] Robert A. Lewis,et al. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function , 1985 .
[19] M. Weinrich,et al. Prevalence of Raynaud phenomenon in the general population. A preliminary study by questionnaire. , 1986, Journal of chronic diseases.
[20] J. Salmon,et al. Leukocyte-derived metabolites of arachidonic acid in ischemia-induced myocardial injury. , 1987, Federation proceedings.
[21] H. Shimokawa,et al. Effects of dietary supplementation with cod-liver oil on endothelium-dependent responses in porcine coronary arteries. , 1987, Circulation.
[22] P. Libby,et al. Interleukin 1 induces interleukin 1. II. Recombinant human interleukin 1 induces interleukin 1 production by adult human vascular endothelial cells. , 1987, Journal of immunology.
[23] J. Kremer,et al. Fish-oil fatty acid supplementation in active rheumatoid arthritis. A double-blinded, controlled, crossover study. , 1987, Annals of internal medicine.